Lee Kalowski - Jul 29, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Signature
/s/ Lee Kalowski
Stock symbol
BCYC
Transactions as of
Jul 29, 2021
Transactions value $
-$373,448
Form type
4
Date filed
7/30/2021, 06:21 PM
Next filing
Aug 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $20.4K +12.5K $1.63* 12.5K Jul 29, 2021 Direct F1, F2
transaction BCYC Ordinary Shares Sale -$281K -9K -71.97% $31.24 3.5K Jul 29, 2021 Direct F1, F3
transaction BCYC Ordinary Shares Sale -$103K -3.2K -91.44% $32.13 300 Jul 29, 2021 Direct F1, F4
transaction BCYC Ordinary Shares Sale -$9.84K -300 -100% $32.81 0 Jul 29, 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -12.5K -15.67% $0.00 67.3K Jul 29, 2021 Ordinary Shares 12.5K $1.63 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.
F2 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39511 to GBP 1.00 as of July 29, 2021.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.73 to $31.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.77 to $32.76 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.78 to $32.86 inclusive.
F6 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date.